Who owns the AMORSOL trademark?

The AMORSOL trademark is owned by Ascendia Pharmaceuticals LLC.

What class is the AMORSOL trademark registered in?

The AMORSOL trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for AMORSOL?

The USPTO serial number for AMORSOL is 86306229.

What is the registration number for AMORSOL?

AMORSOL is registered under USPTO registration number 4842224.

Sealvo

Home Search: AMORSOLAMORSOL #86306229

Back

Updated Oct 13, 2026·40 searches this week

View on USPTO TSDR Find similar marks

AMO

USPTO Trademark Record

REGISTERED

AMORSOL

SN 86306229·Reg 4842224·Filed Jun 11, 2014

Owner Ascendia Pharmaceuticals LLC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

AMORSOL (Serial No. 86306229), Registration No. 4842224, is a registered US trademark filed on Jun 11, 2014 by Ascendia Pharmaceuticals LLC. This trademark covers Class 042 (Scientific, technology & SaaS services).

Section 8/9 declaration window: October 29, 2035

Mark Intelligence

AMORSOL (Reg. #4842224) is a registered US trademark that has been protecting its owner, Ascendia Pharmaceuticals LLC, since 2014. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 11, 2014

SERIAL

86306229

REG#

4842224

REGISTERED

Oct 27, 2015

Filing Information

StatusREGISTERED

Filing DateJun 11, 2014

Serial Number86306229

Registration No.4842224

Registration DateOct 27, 2015

Status DateJan 29, 2026

Published for OppositionApr 14, 2015

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application CurrentlySection 8 AcceptedSection 15 Acknowledged

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Nov 02, 2014

First use in commerce: Apr 30, 2015

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

37 events

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Jan 29, 2026

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Jan 29, 2026

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Jan 29, 2026

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jan 26, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 & 9 RECEIVED

Oct 24, 2025

TEAS SECTION 8 & 9 RECEIVED

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Oct 28, 2024

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Feb 11, 2021

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Feb 11, 2021

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Feb 05, 2021

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 & 15 RECEIVED

Oct 27, 2020

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Oct 27, 2020

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Oct 27, 2015

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 24, 2015

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Sep 23, 2015

STATEMENT OF USE PROCESSING COMPLETE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 23, 2015

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 22, 2015

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Sep 15, 2015

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Sep 15, 2015

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 09, 2015

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 14, 2015

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 14, 2015

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 25, 2015

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 10, 2015

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Mar 02, 2015

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 02, 2015

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 02, 2015

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 02, 2015

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 23, 2015

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 23, 2015

TEAS RESPONSE TO OFFICE ACTION RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 23, 2015

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 23, 2015

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NON-FINAL ACTION WRITTEN

Sep 25, 2014

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 25, 2014

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 25, 2014

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 22, 2014

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 21, 2014

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 14, 2014

NEW APPLICATION ENTERED

Other Marks by Ascendia Pharmaceuticals LLC

Additional USPTO filings from the same owner.

EMU

EMULSOL

86306205

Ascendia Pharmaceuticals LLC

REGISTERED

ACU

ACUTE THERAPEUTICS

86830651

Ascendia Pharmaceuticals, LLC

ABANDONED

ACU

ACUTE THERAPEUTICS

86830573

Ascendia Pharmaceuticals, LLC

ABANDONED

NAN

NANOSOL

86306219

Ascendia Pharmaceuticals LLC

ABANDONED

Other Marks by James Klobucar

Additional USPTO filings handled by the same attorney of record.

NOG

NOGGIN NAPKIN

98889131

REGISTERED

BHA

BHARAT PAYROLL

99068452

REGISTERED

THE

THE SALEM OAK

88724323

REGISTERED

88745780

REGISTERED

AMORSOL

Run a conflict check

Other Marks by Ascendia Pharmaceuticals LLC

Other Marks by James Klobucar

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company